HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoli Lan Selected Research

picolinamide

11/2017Synthesis and Preclinical Evaluation of 18F-PEG3-FPN for the Detection of Metastatic Pigmented Melanoma.
1/2016Imaging malignant melanoma with (18)F-5-FPN.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoli Lan Research Topics

Disease

73Neoplasms (Cancer)
10/2022 - 01/2005
16Neoplasm Metastasis (Metastasis)
10/2022 - 01/2017
12Breast Neoplasms (Breast Cancer)
10/2022 - 08/2013
12Melanoma (Melanoma, Malignant)
10/2022 - 05/2014
5Triple Negative Breast Neoplasms
05/2022 - 02/2020
4Myocardial Infarction
05/2022 - 01/2014
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2015
4Hypoxia (Hypoxemia)
10/2021 - 07/2018
3Thyroid Neoplasms (Thyroid Cancer)
07/2021 - 03/2012
3COVID-19
01/2021 - 01/2020
3Prostatic Neoplasms (Prostate Cancer)
01/2021 - 03/2010
3Papillary Thyroid Cancer
04/2019 - 03/2012
2Acute Kidney Injury (Acute Renal Failure)
01/2023 - 12/2020
2Carcinoma (Carcinomatosis)
01/2022 - 03/2010
2Inflammation (Inflammations)
01/2022 - 08/2007
2Multiple System Atrophy
10/2021 - 01/2019
2Parkinson Disease (Parkinson's Disease)
10/2021 - 01/2019
2Colonic Neoplasms (Colon Cancer)
05/2021 - 01/2017
2Liver Diseases (Liver Disease)
05/2021 - 01/2020
2Nasopharyngeal Carcinoma
01/2021 - 01/2018
2Oncogenic osteomalacia
06/2020 - 06/2019
2Reperfusion Injury
01/2020 - 10/2019
2Lymphoma (Lymphomas)
01/2020 - 03/2019
2Infarction (Infarctions)
09/2017 - 01/2005
2Mesothelioma
04/2011 - 04/2011
1Infections
10/2022
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2022
1Melena
07/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022

Drug/Important Bio-Agent (IBA)

28Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2022 - 09/2013
10Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2014
8Pharmaceutical PreparationsIBA
04/2022 - 01/2017
868Ga-FAPIIBA
01/2022 - 12/2020
7Radioisotopes (Radionuclides)IBA
04/2022 - 05/2014
6Peptides (Polypeptides)IBA
01/2022 - 07/2014
5AntibodiesIBA
10/2022 - 03/2010
5Estrogen ReceptorsIBA
10/2021 - 03/2012
4RadiopharmaceuticalsIBA
07/2022 - 07/2017
4Melanins (Melanin)IBA
07/2022 - 01/2016
41-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2022 - 01/2018
4IntegrinsIBA
01/2022 - 01/2017
4Monoclonal AntibodiesIBA
01/2020 - 05/2015
4ErbB Receptors (EGF Receptor)IBA
01/2018 - 03/2012
4Immunoglobulin FragmentsIBA
11/2016 - 03/2010
3Molecular Probes (Molecular Probe)IBA
10/2022 - 05/2015
3AcidsIBA
04/2022 - 01/2020
3Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 03/2012
3Oxygen (Dioxygen)IBA
03/2021 - 07/2018
3Immunoglobulin G (IgG)IBA
01/2021 - 01/2017
3Fluorine-18IBA
01/2021 - 08/2013
3Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2018 - 11/2016
3LigandsIBA
01/2018 - 04/2011
3Single-Chain AntibodiesIBA
01/2018 - 11/2016
2Cisplatin (Platino)FDA LinkGeneric
01/2023 - 12/2020
2AntigensIBA
10/2022 - 01/2020
2Photosensitizing Agents (Photosensitizers)IBA
04/2022 - 07/2018
2cyanine dye 5IBA
01/2022 - 11/2016
2CD13 Antigens (Alanine Aminopeptidase)IBA
01/2022 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
2human ERBB2 proteinIBA
10/2021 - 02/2020
2gallium 68 PSMA-11IBA
01/2021 - 01/2021
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2021
2Biological ProductsIBA
01/2021 - 01/2017
2gallium Ga 68 dotatateIBA
10/2020 - 05/2020
2Somatostatin Receptors (Somatostatin Receptor)IBA
05/2020 - 06/2019
2Integrin alpha4beta1 (VLA-4)IBA
01/2020 - 10/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 10/2019
2CarbohydratesIBA
01/2020 - 05/2018
2PorphyrinsIBA
12/2019 - 01/2018
22- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
11/2019 - 01/2019
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2019 - 01/2019
2Phosphates (Orthophosphate)IBA
06/2019 - 05/2014
2Choline (Choline Chloride)IBA
01/2019 - 11/2017
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 01/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2018 - 09/2017
2Chelating AgentsIBA
10/2018 - 09/2018
2Tumor Biomarkers (Tumor Markers)IBA
05/2018 - 04/2017
2N- (2- (diethylamino)ethyl)- 5- fluoropicolinamideIBA
11/2017 - 07/2017
2picolinamideIBA
11/2017 - 01/2016
2tyrosyl-isoleucyl-glycyl-seryl-arginineIBA
08/2007 - 01/2005
1CurcuminIBA
01/2023
1Povidone (Crospovidone)IBA
01/2023
1Keratin-14 (Keratin 14)IBA
10/2022
1RNA (Ribonucleic Acid)IBA
10/2022
1NanogelsIBA
05/2022
1HydrogelsIBA
05/2022
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2022

Therapy/Procedure

26Therapeutics
04/2022 - 03/2010
6Precision Medicine
01/2021 - 05/2014
5Radiotherapy
04/2022 - 12/2018
3Drug Therapy (Chemotherapy)
01/2022 - 02/2019
3Photochemotherapy (Photodynamic Therapy)
01/2022 - 07/2018
3Radioimmunotherapy
01/2020 - 06/2015
2Computer-Assisted Surgery (Image Guided Surgery)
05/2021 - 01/2020
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021 - 09/2017
2Intravenous Injections
07/2017 - 05/2014
1Immunotherapy
10/2022
1Photothermal Therapy
05/2022
1Injections
05/2022